Carbamazepine: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Category: Drugs]] [[Category:Anticonvulsant medication]] | [[Category: Drugs]] [[Category:Anticonvulsant medication]] | ||
'''Carbamazepine'''(中文: [[卡馬西平]]) | '''Carbamazepine'''(中文: [[卡馬西平]]) is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures. It is not effective for absence or myoclonic seizures. | ||
It is used in schizophrenia and as a second-line agent in the management of bipolar disorder unresponsive to lithium. | It is used in schizophrenia and as a second-line agent in the management of bipolar disorder unresponsive to lithium. | ||
==Drug Names== | |||
{| class="wikitable" | |||
!Generic Name 藥名 | |||
!HA Code 藥物代碼 | |||
!Classification藥物分類 | |||
|- | |||
|Carbamazepine Suspension 100mg/5ml | |||
|CARB49 | |||
|P1S1S3 | |||
|} | |||
==Mechanism of Action== | |||
Anticonvulsant medication. It is a sodium channel blocker. It binds to sodium channels and suppresses repetitive neuronal firing. | |||
==Dosage== | |||
{| class = "wikitable" | |||
!style="text-align: left"| Epilepsy | |||
|''Oral'': initially 100 – 200 mg 1-2 times daily, increased slowly by increments of up 200 mg daily every week to an usual maintenance dose of 0.8 – 1.2 g daily in divided doses; up to 2 g daily may occasionally be necessary. | |||
''By rectum'': for short-term use (Max. 7 days) when oral therapy temporarily not possible; 125-mg suppository approximately equivalent to 100-mg tablet, but final adjustment should always depend on clinical response. Max. 1 g daily in 4 divided doses. | |||
Doses in children, for use as adjunctive therapy in children aged 6 years and over, and as monotherapy in those aged 12 years or over. | |||
6-12 years (adjunctive therapy): | |||
*initially 10 mg/kg (max. 300 mg) once daily on day 1, then | |||
*10 mg /kg (max. 300mg) twice daily on day 2, then | |||
*10mg mg/kg (max. 300 mg) 3 times daily on day 3; | |||
*Usual dose 25 – 35 mg/kg daily in 3 divided doses; | |||
*Max. 70 mg/kg daily in 3 divided doses. | |||
|- | |||
!style="text-align: left"| Neuropathic Pain | |||
|By mouth: | |||
*300 mg once daily on day 1, then | |||
*300 mg twice daily on day 2, then | |||
*300 mg 3 times daily on day 3. | |||
Alternatively, 300 mg 3 times daily on day 1, then increased according to response in steps of 300mg (in 3 divided doses) every 2-3 days up to max. 3.6 g daily. | |||
|- | |||
!style="text-align: left"| Migraine prophylaxis | |||
|By mouth: | |||
*initially 300 mg daily, increased according to response up to 2.4 g daily in divided doses. | |||
|} | |||
Revision as of 21:38, 7 October 2020
Carbamazepine(中文: 卡馬西平) is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures. It is not effective for absence or myoclonic seizures. It is used in schizophrenia and as a second-line agent in the management of bipolar disorder unresponsive to lithium.
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Carbamazepine Suspension 100mg/5ml | CARB49 | P1S1S3 |
Mechanism of Action
Anticonvulsant medication. It is a sodium channel blocker. It binds to sodium channels and suppresses repetitive neuronal firing.
Dosage
| Epilepsy | Oral: initially 100 – 200 mg 1-2 times daily, increased slowly by increments of up 200 mg daily every week to an usual maintenance dose of 0.8 – 1.2 g daily in divided doses; up to 2 g daily may occasionally be necessary.
By rectum: for short-term use (Max. 7 days) when oral therapy temporarily not possible; 125-mg suppository approximately equivalent to 100-mg tablet, but final adjustment should always depend on clinical response. Max. 1 g daily in 4 divided doses.
6-12 years (adjunctive therapy):
|
|---|---|
| Neuropathic Pain | By mouth:
Alternatively, 300 mg 3 times daily on day 1, then increased according to response in steps of 300mg (in 3 divided doses) every 2-3 days up to max. 3.6 g daily. |
| Migraine prophylaxis | By mouth:
|
